Evaluating the Wilms' tumour antigen (WT1) as a target for the immunotherapy of malignancies
The Wilms' tumour antigen 1 (WT1) is a transcription factor which is over-expressed in several leukaemias and solid tumours. Currently, there is limited information about the expression and immunogenicity of WT1 in prostate cancer. I used immunohistochemistry to analyse WT1 expression in prosta...
Main Author: | King, Judith |
---|---|
Published: |
University College London (University of London)
2008
|
Subjects: | |
Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.505296 |
Similar Items
-
An investigation of mouse Basp1 and Wt1-AS, genes involved in the regulation of the Wilms' Tumour suppressor protein, Wt1
by: Allsop, Joanne
Published: (2008) -
Genetic and development interactions between the genes encoding Wilms tumour 1 (Wt1) and B-catenin (Ctnnb1)
by: Ozdemir, Derya Deniz
Published: (2010) -
Examination of the role of the Wilms' tumour suppressor gene (Wt1) in mouse development and neoplasia using a homozygous Denys-Drash syndrome mutation
by: Wagner, Kate J.
Published: (2001) -
Identification of a novel Wilms' tumour 1 binding protein
by: Little, Natalie Ann
Published: (1999) -
Identification of tumour associated antigens as potential targets for the immunotherapy of B-cell chronic lymphocytic leukaemia (B-CLL)
by: Abdulmajed, Hind Abdulrazak Yassin
Published: (2008)